Pulmicort Inhalation Powder 180Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Pulmicort: Inhalation powder (180mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Pulmicort Flexhaler 180mcg/act

What is this Medicine?

BUDESONIDE (bue DES oh nide) is a corticosteroid. It helps to decrease inflammation in your lungs. This medicine is used to treat the symptoms of asthma. Never use this medicine for an acute asthma attack.

CVS Pharmacy Patient Statistics for Pulmicort: Inhalation powder(180mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Pulmicort Flexhaler 180mcg/actuation Powder for Inhalation

NDC: 001860916
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Asthma, Bronchospasm Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Exercise-induced Bronchospasm Prophylaxis, Chronic Obstructive Pulmonary Disease (COPD)

Storage Information
Store in a dry place
Store at controlled room temperature (between 68 and 77 degrees F)
Pulmicort Flexhaler 180mcg/actuation Powder for Inhalation

Reported Side Effects for Pulmicort Flexhaler 180mcg/actuation Powder for Inhalation

Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Cataracts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Death Of Bone Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Breathing Difficulties Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Irritability Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bruises Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Churg-Strauss Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Allergic Skin Reaction Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<6.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
1.0-2.9%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-3.0%*
Severity: MILD
Onset: RAPID
Ear Pain Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Excessive Mucle Tone Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Hoarseness Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Hoarseness Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Eye Infection Incidence:
1.0-2.9%*
Severity: MODERATE
Onset: DELAYED
Migraine Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Fainting Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
1.0-8.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.8-13.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
2.0-9.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
2.0-10.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
2.0-8.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
2.1-12.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
2.7%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.0-37.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
>3.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
>3.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
>3.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Pulmicort Flexhaler 180mcg/actuation Powder for Inhalation

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Pulmicort Flexhaler 180mcg/actuation Powder for Inhalation(Budesonide)
Grapefruit juice and Budesonide(Budesonide)
Grapefruit juice can increase the amount of oral Budesonide (Entocort-EC) that your body absorbs. Grapefruit juice and grapefruit-containing foods may increase the side effects of oral Budesonide. If possible, you should avoid grapefruit or grapefruit juice while taking Entocort-EC. At the very least, avoid large changes (i.e., either increases or decreases) in your daily intake of grapefruit and grapefruit juice. Grapefruit juice is not expected to interact significantly with inhaled or nasal Budesonide (Pulmicort or Rhinocort).
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Pulmicort

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5